Delivery Order SPE2DB22D2007-SPE2DB26FH6PL
- Not listed
- AmerisourceBergen Drug Corp was awarded a $1,040.19 delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This is a firm fixed-price contract with an ultimate completion date of September 26, 2025, and represents performance at the company's Conshohocken, Pennsylvania headquarters. The award was competitively procured with no set-aside designation and serves as a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,372.29 by the Defense Logistics Agency (DLA) on June 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 25, 2025. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections. The contract carries a ceiling value of $3,005.43 and utilizes firm fixed price pricing, with an ultimate completion date of October 31, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The contract, valued at $20,199.71, is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. This award was made on a competitive basis with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,448.81 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with a ceiling value of $3,265.08. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a ceiling value of $4,897.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $24,969.91 by the Defense Logistics Agency for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL) with a firm fixed-price contract structure. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a contract value of $4,568.72. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6PLDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 29, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections with a ceiling value of $1,498.88. This is a firm fixed-price contract with an ultimate completion date of October 30, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medical commodities to support federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Mounjaro is a diabetes medication, consistent with the company's extensive portfolio of pharmaceutical products delivered through its DLA contracts supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/29/25 |